115 results

• Andexxa Recall Announced After FDA Says Xarelto, Eliquis Reversal Agent Risks Outweigh Benefits

  December 22, 2025

  Irvin Jackson

  AstraZeneca is removing its blood thinner reversal agent Andexxa from the market after the FDA determined the drug's blood clot risks outweigh its benefits.

• Macular Degeneration Eye Hemorrhage Risks Linked to Blood Thinners: Study

  September 18, 2025

  Martha Garcia

  The use of blood thinners and antiplatelet medications appear to increase the risk of eye bleeds in patients with macular degeneration, according to a new study.

• Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis

  November 21, 2024

  Irvin Jackson

  Safety concerns linked to Andexxa, the reversal agent for newer blood thinners like Xarelto and Eliquis, will be discussed at an FDA advisory panel meeting today, after postmarketing studies indicated the drug doubled the risks of blood clots and death.

• Study Links Serious Bleeding Risks to Diltiazem Combination Therapy With Anticoagulants for Atrial Fibrillation

  April 19, 2024

  Martha Garcia

  Cardizem and Viazem could increase the risk of bleeding in atrial fibrillation patients being treated with Xarelto and Eliquis, a new study warns.

• Eliquis No Better Than Aspirin for Preventing Some Strokes in A-Fib Patients: Study

  February 16, 2024

  Martha Garcia

  A new study indicates Eliquis performed no better than aspirin at preventing follow-up strokes among patients with atrial fibrillation.

• Eliquis Lowers Stroke Risk, But Side Effects Linked to Higher Risk of Major Bleeding: Study

  January 17, 2024

  Katherine McDaniel

  A new study reveals Eliquis decreases the risk of stroke in patients with subclinical atrial fibrillation, but at the cost of an increased risk of major bleeding events.

• Blood Thinner Extended Use Study Finds Little Difference in Warfarin, Xarelto, Eliquis Bleeding Rates

  March 18, 2022

  Irvin Jackson

  A new study finds little difference in major bleeding events between the newer blood thinners Xarelto and Eliquis and the older blood thinner warfarin they were supposed to replace.

• Blood Thinners May Face Increased Bleeding Risks During Respiratory Tract Infections: Study

  January 11, 2022

  Irvin Jackson

  A new study links respiratory tract infections to an increased risk of bleeding events in patients taking commonly used blood thinners.

• Study Links Xarelto To Increased Risk of Strokes and Brain Bleeds: Study

  December 28, 2021

  Irvin Jackson

  New research indicates users of Xarelto face a greater risk of brain bleeds and strokes than those who take Eliquis.

• Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study

  October 15, 2021

  Russell Maas

  CDC researchers report that blood thinners and insulin account for the largest number of emergency room visits due to adverse drug reactions.